Fresh off Phase III success, Otonomy shoots for an $86M IPO

In the event you are for embryonic stem research then you’ll definitely find the following information useful. Our team are Stem cell professionals have assembled this post below in which we imagine you will find enlightening and of use when shopping for regenerative medicine companies list. Please search around the pages of our web-site for past articles or reviews and videos; also look out for additional specifics about the topic from our day by day blog and article posting.

San Diego biotech Otonomy isn’t biding its time, filing to go public in an $86.3 million IPO just three days after unveiling positive Phase III results for its lead drug….Fresh off Phase III success, Otonomy shoots for an $86M IPO

We hope you really liked this article we provided above and you thought it was informative and useful; for anyone who is looking for info? We have collected more useful and related links below. Of course, we’re very pleased if you could share this article together with your social networking friends and supporters. Inform us should there be anything very special you’re looking for or whatever further questions you may have.

Get more info here embryonic stem research


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s